Human ICAM-5 Biotinylated Antibody Summary
Ala28-Glu570
Accession # Q9UMF0
Applications
Human ICAM-5 Sandwich Immunoassay
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
View Larger
Human ICAM‑5 ELISA Standard Curve. Recombinant Human ICAM-5 protein (Catalog # 1950-M5) was serially diluted 2-fold and captured by Mouse Anti-Human ICAM-5 Monoclonal Antibody (Catalog # MAB1950) coated on a Clear Polystyrene Microplate (Catalog # DY990). Goat Anti-Human ICAM-5 Biotinylated Antigen Affinity-purified Polyclonal Antibody (Catalog # BAF1950) was biotinylated and incubated with the protein captured on the plate. Detection of the standard curve was achieved by incubating Streptavidin-HRP (Catalog # DY998) followed by Substrate Solution (Catalog # DY999) and stopping the enzymatic reaction with Stop Solution (Catalog # DY994).
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: ICAM-5
Intercellular adhesion molecule-5 (ICAM-5), also known as telencephalin, is a cell surface glycoprotein belonging to the immunoglobulin superfamily. Human ICAM-5 consists of an 832 amino acid (aa) extracellular domain containing 9 immunoglobulin (Ig) domains and 15 N-glycosylation sites, a 28 aa transmembrane domain, and a 64 aa cytoplasmic domain. ICAM-5 shares 38‑55% aa identity with other ICAMs, being most closely related to ICAM-1 (50% identity) and ICAM-3 (55% identity) (1). Human and mouse ICAM-5 share 85% aa identity. The tissue distribution of ICAM-5 is unique among ICAMs, being expressed only in telencephalic regions of the central nervous system (2). Like other ICAMs, ICAM-5 binds to the leukocyte integrin LFA-1 (CD11a/CD18) (3). Binding of ICAM-5 to LFA-1 is dependent on the first amino terminal Ig domain of ICAM-5 (4). ICAM-5 also displays homophilic binding, with the amino terminal Ig domain binding to Ig domains 4‑5. Homophilic binding of ICAM-5 is dependent of ICAM-5 being in a monomeric form. The monomeric form of ICAM-5 is found during dendritogenesis in developing brain, whereas a high molecular weight complex is found in mature neurons (5).
- Mizuno, T. et al. (1997) J. Biol. Chem. 272:1156.
- Yoshihara, Y. et al. (1994) Neuron 12:541.
- Tain, L. et al. (1997) J. Immunol. 158:928.
- Tain, L. et al. (2000) Eur. J. Immunol. 30:810.
- Tain, L. et al. (2000) J. Immunol. 150:243.
Product Datasheets
Citation for Human ICAM-5 Biotinylated Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
1 Citation: Showing 1 - 1
-
The TARC/sICAM5 Ratio in Patient Plasma is a Candidate Biomarker for Drug Resistant Epilepsy
Authors: John R. Pollard, Ofer Eidelman, Gregory P. Mueller, Clifton L. Dalgard, Peter B. Crino, Christopher T. Anderson et al.
Frontiers in Neurology
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human ICAM-5 Biotinylated Antibody
There are currently no reviews for this product. Be the first to review Human ICAM-5 Biotinylated Antibody and earn rewards!
Have you used Human ICAM-5 Biotinylated Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
